Stage Iv Bladder Cancer Ajcc V6: Disease Bioinformatics
Bladder cancer typically originates in the cells that line the interior of the bladder. Because most cases are diagnosed at an early stage, bladder cancer is considered highly treatable. Risk for developing cancer is increased with smoking, age, exposure to certain chemicals, certain diabetes medications, and frequent bladder inflammations. However, bladder cancer is most common in white men. Treatments for bladder cancer include surgery, immunotherapy, chemotherapy, and radiation therapy. Stage IV is considered the most aggressive and progressed form of bladder cancer. To be diagnosed with stage IV, one of multiple scenarios must occur. One situation is that the cancer has grown through the bladder wall and has infected the abdominal wall, but has not spread to nearby lymph nodes or distant locations. Another scenario that would warrant a stage IV diagnosis is that the cancer has spread to nearby lymph nodes but not to other locations throughout the body. Or, in the most progressed scenario, the cancer has localized on lymph nodes as well as various locations throughout the body, such as the bones, liver, or lungs.
Stage Iv Bladder Cancer Ajcc V6 Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Stage Iv Bladder Cancer Ajcc V6 below!
For more information on how to use Laverne, please read the How to Guide.
We have 2466 products for the study of Stage Iv Bladder Cancer Ajcc V6 that can be applied to Western Blot, Chromatin Immunoprecipitation, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry, Chromatin Immunoprecipitation (ChIP) from our catalog of antibodies and ELISA kits.